{"DataElement":{"publicId":"4135192","version":"1","preferredName":"Disease or Disorder Retinoblastoma Status","preferredDefinition":"the abnormal conditions related to a malignant tumor that originates in the nuclear layer of the retina.","longName":"RETDsSt","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"4135166","version":"1","preferredName":"Disease or Disorder Retinoblastoma Evaluation","preferredDefinition":"information related to the abnormal condition of a malignant tumor that originates in the nuclear layer of the retina.","longName":"RETDsEvl","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"2404658","version":"1","preferredName":"Diseases and Disorders","preferredDefinition":"A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.","longName":"C2991","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Disease or Disorder","conceptCode":"C2991","definition":"Any abnormal condition of the body or mind that causes discomfort, dysfunction, or distress to the person affected or those in contact with the person. The term is often used broadly to include injuries, disabilities, syndromes, symptoms, deviant behaviors, and atypical variations of structure and function.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"005AD6E5-0651-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"PWEST","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4135211","version":"1","preferredName":"Retinoblastoma Evaluation","preferredDefinition":"A malignant tumor that originates in the nuclear layer of the retina. As the most common primary tumor of the eye in children, retinoblastoma is still relatively uncommon, accounting for only 1% of all malignant tumors in pediatric patients. These tumors may be multifocal, bilateral, congenital, inherited, or acquired. Seventy-five percent of retinoblastomas are unilateral; 60% occur sporadically. A predisposition to retinoblastoma has been associated with 13q14 cytogenetic abnormalities. Patients with the inherited form also appear to be at increased risk for secondary nonocular malignancies such as osteosarcoma, malignant fibrous histiocytoma, and fibrosarcoma.:Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","longName":"C7541:C25214","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Retinoblastoma","conceptCode":"C7541","definition":"A malignant tumor that originates in the nuclear layer of the retina. As the most common primary tumor of the eye in children, retinoblastoma is still relatively uncommon, accounting for only 1% of all malignant tumors in pediatric patients. Approximately 95% of cases are diagnosed before age 5. These tumors may be multifocal, bilateral, congenital, inherited, or acquired. Seventy-five percent of retinoblastomas are unilateral; 60% occur sporadically. A predisposition to retinoblastoma has been associated with 13q14 cytogenetic abnormalities. Patients with the inherited form also appear to be at increased risk for secondary nonocular malignancies such as osteosarcoma, malignant fibrous histiocytoma, and fibrosarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Evaluation","conceptCode":"C25214","definition":"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1ADD469-1EF1-33D9-E040-BB89AD436C6F","latestVersionIndicator":"Yes","beginDate":"2014-02-05","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-05","modifiedBy":"ONEDATA","dateModified":"2014-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1AD5DCD-593F-BB05-E040-BB89AD435777","latestVersionIndicator":"Yes","beginDate":"2014-02-05","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-05","modifiedBy":"MAESKEB","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4135191","version":"1","preferredName":"Retinoblastoma Disease Status","preferredDefinition":"the abnormal conditions of a malignant tumor that originates in the nuclear layer of the retina.","longName":"RETDsSt","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Type IV Response","valueDescription":"Type IV Response","ValueMeaning":{"publicId":"4135231","version":"1","preferredName":"Type IV Response","longName":"4135231","preferredDefinition":"Type IV with flat chorioretinal scars, or avascular, linear, white gliosis regression of all retinal tumors documented by at least two EUAs minimum of three weeks apart. No evidence of active vitreous tumor. No evidence of new lesions. Complete response is dated from the time all lesions have complete regression.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1AE5E6B-C632-C6F5-E040-BB89AD43219A","latestVersionIndicator":"Yes","beginDate":"2014-02-05","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-05","modifiedBy":"COOPERM","dateModified":"2020-03-16","changeDescription":"Removed special characters for MDR data migration. 3.16.20 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F1AE5E6B-C64B-C6F5-E040-BB89AD43219A","beginDate":"2014-02-05","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-05","modifiedBy":"ONEDATA","dateModified":"2014-02-05","deletedIndicator":"No"},{"value":"Type III Response","valueDescription":"Type III Response","ValueMeaning":{"publicId":"4135232","version":"1","preferredName":"Type III Response","longName":"4135232","preferredDefinition":"Type III regression pattern in some lesions(i.e. not all lesions have Type I and/or Type IV regression pattern).  No evidence of active vitreous tumor. Partial response is dated from the time of first observation. In addition, there can be no appearance of new lesions or progression of any lesion.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1AE5E6B-C655-C6F5-E040-BB89AD43219A","latestVersionIndicator":"Yes","beginDate":"2014-02-05","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F1AE5E6B-C66E-C6F5-E040-BB89AD43219A","beginDate":"2014-02-05","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-05","modifiedBy":"ONEDATA","dateModified":"2014-02-05","deletedIndicator":"No"},{"value":"Type II Response","valueDescription":"Type II Response","ValueMeaning":{"publicId":"4135233","version":"1","preferredName":"Type II Response","longName":"4135233","preferredDefinition":"Reduction in size with Type II.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1AE5E6B-C678-C6F5-E040-BB89AD43219A","latestVersionIndicator":"Yes","beginDate":"2014-02-05","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F1AE5E6B-C691-C6F5-E040-BB89AD43219A","beginDate":"2014-02-05","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-05","modifiedBy":"ONEDATA","dateModified":"2014-02-05","deletedIndicator":"No"},{"value":"Type I Response","valueDescription":"Type I Response","ValueMeaning":{"publicId":"4135234","version":"1","preferredName":"Type I Response","longName":"4135234","preferredDefinition":"Complete Type I regression pattern with calcification.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1AE5E6B-C69B-C6F5-E040-BB89AD43219A","latestVersionIndicator":"Yes","beginDate":"2014-02-05","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F1AE5E6B-C6B4-C6F5-E040-BB89AD43219A","beginDate":"2014-02-05","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-05","modifiedBy":"ONEDATA","dateModified":"2014-02-05","deletedIndicator":"No"},{"value":"Stable Disease","valueDescription":"Stable Disease (SD)","ValueMeaning":{"publicId":"4135235","version":"1","preferredName":"Stable Disease (SD)","longName":"4135235","preferredDefinition":"No change in size/regression of retinal tumors and/or persistence of any active vitreous tumor. No evidence of new lesions.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1AE5E6B-C6BE-C6F5-E040-BB89AD43219A","latestVersionIndicator":"Yes","beginDate":"2014-02-05","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F1AE5E6B-C6D7-C6F5-E040-BB89AD43219A","beginDate":"2014-02-05","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-05","modifiedBy":"ONEDATA","dateModified":"2014-02-05","deletedIndicator":"No"},{"value":"Metastatic Systemic Recurrence","valueDescription":"Metastatic Systemic Recurrence","ValueMeaning":{"publicId":"4135236","version":"1","preferredName":"Metastatic Systemic Recurrence","longName":"4135236","preferredDefinition":"Tumor metastases to bone, bone marrow, lymph node, brain and/or other distant organ outside eye.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1AE5E6B-C6E1-C6F5-E040-BB89AD43219A","latestVersionIndicator":"Yes","beginDate":"2014-02-05","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F1AE5E6B-C6FA-C6F5-E040-BB89AD43219A","beginDate":"2014-02-05","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-05","modifiedBy":"ONEDATA","dateModified":"2014-02-05","deletedIndicator":"No"},{"value":"Extraocular Recurrence","valueDescription":"Extraocular Recurrence","ValueMeaning":{"publicId":"4135237","version":"1","preferredName":"Extraocular Recurrence","longName":"4135237","preferredDefinition":"Tumor regrowth involving optic nerve, and/or orbit.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1AE5E6B-C704-C6F5-E040-BB89AD43219A","latestVersionIndicator":"Yes","beginDate":"2014-02-05","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F1AE5E6B-C71D-C6F5-E040-BB89AD43219A","beginDate":"2014-02-05","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-05","modifiedBy":"ONEDATA","dateModified":"2014-02-05","deletedIndicator":"No"},{"value":"Vitreal Recurrence","valueDescription":"Vitreal Recurrence","ValueMeaning":{"publicId":"4135238","version":"1","preferredName":"Vitreal Recurrence","longName":"4135238","preferredDefinition":"Tumor regrowth involving expansion or new onset of vitreous seeding.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1AE5E6B-C727-C6F5-E040-BB89AD43219A","latestVersionIndicator":"Yes","beginDate":"2014-02-05","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F1AE5E6B-C740-C6F5-E040-BB89AD43219A","beginDate":"2014-02-05","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-05","modifiedBy":"ONEDATA","dateModified":"2014-02-05","deletedIndicator":"No"},{"value":"Subretinal Recurrence","valueDescription":"Subretinal Recurrence","ValueMeaning":{"publicId":"4135239","version":"1","preferredName":"Subretinal Recurrence","longName":"4135239","preferredDefinition":"Tumor regrowth involving expansion of new onset of subretinal seeding.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1AE5E6B-C74A-C6F5-E040-BB89AD43219A","latestVersionIndicator":"Yes","beginDate":"2014-02-05","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F1AE5E6B-C763-C6F5-E040-BB89AD43219A","beginDate":"2014-02-05","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-05","modifiedBy":"ONEDATA","dateModified":"2014-02-05","deletedIndicator":"No"},{"value":"Retinal Recurrence","valueDescription":"Retinal Recurrence","ValueMeaning":{"publicId":"4135240","version":"1","preferredName":"Retinal Recurrence","longName":"4135240","preferredDefinition":"Tumor regrowth at prior sites and/or new sites of retinal tumors that canNOT be controlled by local therapy and/or plaque.","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1AE5E6B-C76D-C6F5-E040-BB89AD43219A","latestVersionIndicator":"Yes","beginDate":"2014-02-05","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"F1AE5E6B-C786-C6F5-E040-BB89AD43219A","beginDate":"2014-02-05","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-05","modifiedBy":"ONEDATA","dateModified":"2014-02-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2404650","version":"1","preferredName":"Status","preferredDefinition":"A condition or state at a particular time.","longName":"C25688","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Status","conceptCode":"C25688","definition":"A condition or state at a particular time.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"005AD6E5-057F-6A35-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-09-09","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-09-09","modifiedBy":"ONEDATA","dateModified":"2005-09-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1AD5DCD-5967-BB05-E040-BB89AD435777","latestVersionIndicator":"Yes","beginDate":"2014-02-05","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-05","modifiedBy":"WONGW","dateModified":"2014-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2961451","version":"1","longName":"Children's Oncology Group (COG)","context":"COG","ClassificationSchemeItems":[{"publicId":"2961452","version":"1","longName":"Statistics and Data Center","context":"COG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Disease Status:","type":"Preferred Question Text","description":"Disease Status:","url":null,"context":"COG"}],"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F1AD5DCD-5996-BB05-E040-BB89AD435777","latestVersionIndicator":"Yes","beginDate":"2014-02-05","endDate":null,"createdBy":"WONGW","dateCreated":"2014-02-05","modifiedBy":"WONGW","dateModified":"2014-02-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}